Rchr
J-GLOBAL ID：200901073032079542   Update date: Jan. 31, 2024

Okada Kazumasa

オカダ カズマサ | Okada Kazumasa
Affiliation and department：
University of Occupational and Environmental Health,Japan School of Medicine

About University of Occupational and Environmental Health,Japan School of Medicine


Job title： Associate Professor
Research field  (1)： Neurology
Research keywords  (3)： 多発性硬化症 ,  Neuroimmunology ,  glial cell
Research theme for competitive and other funds  (9)：
  • 2014 - 2017 Assessment of lesions in multiple sclerosis using phase difference-enhanced imaging (PADRE) and quantitative susceptibility mapping (QSM)
  • 2014 - 2017 Selective protein degradation with the aim of developing therapies for neurodegenarative diseases
  • 2007 - 2008 Effect of BDNF on proliferation of leukemic cells and application to the treatment.
  • 2006 - 2007 Role of intercellular electrical coupling in neurological disorders : elucidation of gap junction funciotn
  • 2003 - 免疫性神経疾患の病態・治療に関する研究
Show all
Papers (46)：
  • Mari Miyata, Shingo Kakeda, Tetsuya Yoneda, Satoru Ide, Kazumasa Okada, Hiroaki Adachi, Yukunori Korogi. Superior cerebellar peduncle atrophy of progressive supranuclear palsy on phase difference enhanced imaging: a comparison with Parkinson’s disease. Neuroradiology. 2023
  • Mari Miyata, Shingo Kakeda, Tetsuya Yoneda, Satoru Ide, Kazumasa Okada, Hiroaki Adachi, Yukunori Korogi. Optic radiation atrophy in Lewy body disease with visual hallucination on phase difference enhanced magnetic resonance images. Scientific Reports. 2022. 12. 1
  • Kazumasa Okada, Shingo Kakeda, Masayuki Tahara. Olfactory Dysfunction Reflects Disease Progression in Japanese Patients with Multiple Sclerosis. Internal medicine (Tokyo, Japan). 2022
  • Masayuki Tahara, Tomoko Oeda, Kazumasa Okada, Kazuhide Ochi, Hirofumi Maruyama, Hikoaki Fukaura, Kyoichi Nomura, Yuko Shimizu, Ichiro Nakashima, Tatsuro Misu, et al. Compassionate open-label use of rituximab following a randomised clinical trial against neuromyelitis optica (RIN-2 study): B cell monitoring-based administration. Multiple sclerosis and related disorders. 2022. 60. 103730-103730
  • 田原 将行, 大江田 知子, 岡田 和将, 越智 一秀, 丸山 博文, 野村 恭一, 深浦 彦彰, 中島 一郎, 三須 建郎, 清水 優子, et al. 視神経脊髄炎の再発に対するリツキシマブの有用性検証試験の継続投与試験 RIN-2試験. 臨床神経学. 2021. 61. Suppl. S304-S304
ｍore...
MISC (40)：
  • 山本 燎, 岩中 行己男, 橋本 智代, 足立 弘明, 岡田 和将, 緒方 英紀, 山崎 亮. 抗neurofascin155抗体陽性の中枢末梢連合脱髄症の1例. 臨床神経学. 2021. 61. 6. 430-430
  • 東盛 雄政, 橋本 智代, 長坂 昌平, 山本 淳考, 赤松 直樹, 岡田 和将, 足立 弘明. 抗LGI1抗体陽性自己免疫性脳炎の1例. Journal of Japan Society of Neurological Emergencies & Critical Care. 2021. 34. 1. 76-76
  • 東盛 雄政, 橋本 智代, 長坂 昌平, 山本 淳考, 赤松 直樹, 足立 弘明, 岡田 和将. 抗LGI1抗体陽性自己免疫性脳炎の1例. 臨床神経学. 2021. 61. 1. 71-71
  • 大成 圭子, 岩中 行己男, 橋本 智代, 岡田 和将, 足立 弘明. 経過の早い筋萎縮性側索硬化症患者における臨床症状と針筋電図所見. 臨床神経学. 2020. 60. Suppl. S409-S409
  • 橋本 智代, 岩中 行己男, 大成 圭子, 岡田 和将, 魚住 武則, 足立 弘明. 脳腱黄色腫症の治療に伴う臨床・電気生理学的経時変化. 臨床神経学. 2020. 60. Suppl. S417-S417
ｍore...
Books (1)：
  • Reduced interleukin-1β reactivity in the immune system and the central nervous system of inbred polydipsic mice.
    ELSEVIER Excerpta Medica International Congress Series Control Mechanisms of stress and emotion : Neuro endocrine-based study 1999
Professional career (1)：
  • (BLANK) (University of Occupational and Environmental Health, Japan)
Work history (4)：
  • 2017/04 - 現在 University of Occupational and Environmental Health, Japan Department of Neurology Associate professor
  • 2011/04 - 2016/03 University of Occupational and Environmental Health, Japan Department of Neurology Associate professor
  • 2001 - 2003 University of Occupational and Environmental Health, Japan School of Medicine
  • 2001 - 2003 Research Associate, Faculty of Medicine,
Association Membership(s) (5)：
日本神経免疫学会 ,  日本内科学会 ,  日本神経学会 ,  Movement disorder society of Japan ,  Japanese society of neurological therapeutics
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM